Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/11/2025

Management of Gallstones with Elevated ALP and GGT

Initial Diagnostic Approach

  • The American College of Radiology recommends obtaining abdominal ultrasound immediately as the first-line imaging to evaluate for choledocholithiasis and biliary obstruction in patients with gallstones and elevated ALP and GGT 1, 2
  • The combination of gallstones with elevated ALP and GGT strongly suggests cholestatic liver injury with possible biliary obstruction, requiring urgent evaluation to rule out choledocholithiasis 2

Immediate Imaging Strategy

  • Transabdominal ultrasound is the mandatory first step to assess for dilated intra- or extrahepatic bile ducts, common bile duct stones, and biliary obstruction in patients with gallstones and elevated ALP and GGT 1, 3
  • If ultrasound shows common bile duct stones, proceed directly to ERCP for therapeutic intervention, as recommended by the American College of Gastroenterology 2

Advanced Imaging When Ultrasound is Negative or Equivocal

  • If ultrasound is negative but ALP/GGT remain elevated, proceed to MRI with MRCP, as recommended by the American College of Radiology, to detect choledocholithiasis, biliary strictures, and intrahepatic biliary abnormalities 1, 2, 3
  • MRCP is superior to ultrasound for detecting choledocholithiasis, biliary strictures, and intrahepatic biliary abnormalities, with a sensitivity of 95% and specificity of 90% 1, 2

Critical Decision Points

  • ERCP should be reserved for therapeutic intervention, not diagnosis, due to significant complication rates, as recommended by the American Society for Gastrointestinal Endoscopy 3, 4
  • Confirmed common bile duct stones on imaging, biliary obstruction requiring intervention, and high clinical suspicion despite negative MRCP/EUS are indications for ERCP 2, 3

Additional Laboratory Workup

  • Obtain a complete liver panel, including total and direct bilirubin, AST, ALT, as recommended by the American Association for the Study of Liver Diseases 2
  • Antimitochondrial antibodies (AMA) should be obtained if chronic cholestasis is suspected to rule out primary biliary cholangitis, as recommended by the American Association for the Study of Liver Diseases 3, 4
  • Viral hepatitis serologies should be obtained if risk factors are present, as recommended by the American Association for the Study of Liver Diseases 2

REFERENCES